Peutz-Jeghers Syndrome
Recent clinical, regulatory, research and industry developments relating to this disease.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
- 1 clinical trial expected to report results, the earliest in Q4 2028.
Clinical MilestonesViewHide
- 2025-10-09The Cancer of the Pancreas Screening-5 CAPS5)StudyResults expected Q4 2028
- 2025-10-09ClinicalThe Cancer of the Pancreas Screening-5 CAPS5)StudyResults expected Q4 2028
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes2
- Capsule Endoscopy1
- Double-Balloon Enteroscopy1
Leading journals1
- Endoscopy1
Leading researchers8
- Adler SN1
- Albert J1
- Baltes P1
- Barbaro F1
- Cellier C1
- Charton JP1
- Delvaux M1
- Despott EJ1
Affiliations (unnormalised)6
- Catholic University1
- Centre Hospitalier Lyon Sud1
- Centro Hospitalar do Alto Ave1
- Chaim Sheba Medical Center1
- Clinical Psychology Unit1
- Gedyt Endoscopy Center1
Associated genes
Genes associated with this disease in the canonical knowledge graph (Open Targets evidence). Number shows the association score.
Reference
Authoritative identity, definition & identifiers.
A hereditary disease caused by autosomal dominant mutations involving CHROMOSOME 19. It is characterized by the presence of INTESTINAL POLYPS, consistently in the JEJUNUM, and mucocutaneous pigmentation with MELANIN spots of the lips, buccal MUCOSA, and digits.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.